This announcement is a separate document:
罗欣药业:关于重大资产置换及发行股份购买资产暨关联交易置入资产2021年末减值测试情况的公告
Luoxin Pharmaceutical: Announcement on major asset swaps and issuance of shares to purchase assets and the impairment test of assets placed in related transactions at the end of 2021
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.